Table 2.
The characteristics of the included studies for VHP decontamination (n = 17).
| Characteristics | n or n (%) |
|---|---|
| Publication Year | n = 17 |
| 2010 | 1 (0.05) |
| 2011 | 3 (0.17) |
| 2012 | 3 (0.17) |
| 2014 | 1 (0.05) |
| 2015 | 1 (0.05) |
| 2016 | 2 (0.11) |
| 2017 | 3 (0.17) |
| 2019 | 2 (0.11) |
| 2020 | 1 (0.05) |
| Location | n = 17 |
| United Kingdom | 8 (0.47) |
| Sweden | 3 (0.17) |
| USA | 2 (0.11) |
| Brazil | 1 (0.05) |
| France | 1 (0.05) |
| Germany | 1 (0.05) |
| The Netherlands | 1 (0.05) |
| Hydrogen Peroxide Vapourizing machine | (n = 19) or n% of total machines |
| Aeroclave | 1 (0.05) |
| Bioquell | 1 (0.05) |
| Bioquell BQ-50 | 1 (0.05) |
| Bioquell Clarus C | 2 (0.10) |
| Bioquell Clarus L | 1 (0.05) |
| Bioquell Clarus R | 3 (0.15) |
| Bioquell Clarus S | 1 (0.05) |
| Bioquell Q10 | 4 (0.21) |
| Liquid Verne Veiling equipment | 1 (0.05) |
| Sterinis aHP | 1 (0.05) |
| Steris La Calhene VHP | 1 (0.05) |
| Steris VHP | 1 (0.05) |
| Sterinis system SR2 | 1 (0.05) |
| Assessed Pathogen: | n or n% of total pathogens |
| Candida | (n = 34) |
| Various Candida species | 34 (100) |
| Bacteria | (n = 27) |
| Acholeplasma laidlawii | 1 (0.03) |
| Acinetobacter baumannii | 1 (0.03) |
| Bacillus anthracis (Ames) spores | 1 (0.03) |
| Brucella abortus | 1 (0.03) |
| Burkholderia pseudomallei | 1 (0.03) |
| Clostridium difficile | 1 (0.03) |
| Escherichia coli | 1 (0.03) |
| Geobacillus stearothermophilus biological indicators | 9 (0.33) |
| MDR Acinetobacter baumannii | 1 (0.03) |
| Methicillin-resistant Staphylococcus aureus (MRSA) | 5 (0.18) |
| Mycoplasma pneumoniae | 1 (0.03) |
| Mycoplasma gallisepticum | 1 (0.03) |
| Mycobacterium tuberculosis | 1 (0.03) |
| Vancomycin- resistant Enterococcus (VRE) | 1 (0.03) |
| Yersinia pestis | 1 (0.03) |
| Virus | n = 21 |
| Adenovirus | 2 (0.09) |
| Avian influenza virus (AIV) | 1 (0.04) |
| Escherichia virus MS2 | 1 (0.04) |
| Feline Calicivirus | 3 (0.14) |
| Foot and mouth disease (FMDV) | 1 (0.04) |
| Human adenovirus type 1 | 1 (0.04) |
| Human norovirus | 3 (0.14) |
| Influenza A virus (H1N1) | 1 (0.04) |
| Murine norovirus (MNV) | 3 (0.14) |
| Pseudomonas virus phi6 | 1 (0.04) |
| Poliovirus | 1 (0.04) |
| Rotavirus | 1 (0.04) |
| Swine influenza virus (SwIV) | 1 (0.04) |
| Transmissible Gastroenteritis coronavirus of pigs (TGEV) | 1 (0.04) |
| Characteristics: | |
| Method of inoculation | n = 29, n% of total surfaces |
| Sabouraud’s dextrose agar and fabric | 2 (0.06) |
| Stainless steel 10 mm-diameter discs/coupon | 5 (0.17) |
| Stainless steel 3 mm-diameter discs/coupon | 1 (0.03) |
| Stainless steel 2.2 cm × 2.5 cm disc | 1 (0.03) |
| Tyvek-pouched stainless steel disc/coupon | 5 (0.17) |
| Plastic plates | 2 (0.06) |
| Steel embossing tape 2.5 cm × 5 cm | 1 (0.03) |
| Roller bottle | 1 (0.03) |
| Unspecified stainless steel/coupon | 4 (0.14) |
| Gauze | 1 (0.03) |
| Glass | 1 (0.03) |
| Painted joint tape | 1 (0.03) |
| Wood | 2 (0.06) |
| Ceramic tile | 1 (0.03) |
| N95 Filter medium | 1 (0.03) |
| Efficacy: Log kill | |
| >8 log | 1 |
| >6 log | 4 |
| >4 log | 4 |
| >3 log | 2 |
| <2 log | 2 |
| 1.3–3.5 log reduction | 1 |
| Log reduction not specified | 4 |